USP30 and acute myeloid leukemia: Due to ethical reason, we are currently unable to obtain enough bone marrow of AML patients and healthy subjects to identify the epigenetic changes of USP30-AS1, the expression of USP30-AS1 and their association with the prognosis of AML patients.